Site icon OncologyTube

Molecular tumor boards for personalized medicine

Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Meeting, held in Denver, CO, Jill Kolesar, PharmD, MS, BCPS, FCCP, of the University of Kentucky, Lexington, KY, explains the role of a molecular tumor board, a group of experts in all areas of medicine, including pharmacists, oncologists, geneticists and bioinformaticians.

Exit mobile version